XOMA Corp (XOMA)

Currency in USD
41.22
+0.18(+0.44%)
Real-time Data·
Earnings results expected today
XOMA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
41.0941.48
52 wk Range
22.2942.81
Key Statistics
Prev. Close
41.04
Open
41.2
Day's Range
41.09-41.48
52 wk Range
22.29-42.81
Volume
59.17K
Average Volume (3m)
234.75K
1-Year Change
72.9967%
Book Value / Share
6.77
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
XOMA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
42.67
Upside
+3.51%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

XOMA Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Analyst Ratings

1 Buy
3 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 42.67
(+3.51% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Hold---Downgrade30/04/2026
Lucid Capital Markets
Hold39.00-5.41%66.00Downgrade27/04/2026
Leerink Partners
Buy50.00+21.27%45.00Maintain24/02/2026
TD Cowen
Hold---New Coverage12/02/2026
Leerink Partners
Buy45.00+9.14%-Maintain31/12/2025

XOMA Corp Earnings Call Summary for Q4/2025

  • XOMA Q4 2025 EPS of $0.26 beat forecast of -$0.11 by 336%; revenue reached $13.76M, exceeding estimates by 23.63%
  • Full-year revenue surged 82.8% vs 2024; GAAP net income of $31.7M reversed prior year's $13.8M loss; royalty receipts up 68% to $34M
  • Stock climbed 5.19% to $28.40 in pre-market trading following the earnings beat, reflecting strong investor confidence
  • Company projects continued growth in 2026 driven by diversified portfolio and strategic capital deployment initiatives
  • Key risks include ongoing Janssen Biotech litigation and declining cash reserves from strategic investments despite debt reduction efforts
Last Updated: 18/03/2026, 14:18
Read Full Transcript

Earnings

Latest Release
18/03/2026
EPS / Forecast
0.26 / -0.11
Revenue / Forecast
13.76M / 11.13M
EPS Revisions
Last 90 days

XOMA (XOMA) Income Statement & Profits

Compare XOMA to Peers and Sector

Metrics to compare
XOMA
Peers
Sector
Relationship
P/E Ratio
26.5x0.0x−0.5x
PEG Ratio
0.14−0.360.00
Price/Book
5.9x2.9x2.6x
Price / LTM Sales
9.4x12.5x3.3x
Upside (Analyst Target)
−5.0%90.2%47.1%
Fair Value Upside
Unlock10.2%6.2%Unlock

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
3.24M27.17%132.85M
Other Institutional Investors
11.30M72.83%463.82M
Public Companies & Retail Investors
0.000.00%0.00
Total
14.54M100.00%596.67M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Ligand Pharmaceuticals Incorporated25.68%3,059,678125,569
BVF Partners L.P.21.74%2,590,303106,306

People Also Watch

54.26
DOO
+1.38%
94.02
CMPR
-0.70%
97.97
LGN
+7.18%
251.39
UNF
+0.66%

FAQ

What Is the XOMA (NASDAQ: XOMA) Share Price Today?

The XOMA stock price today is 41.22 USD.

What Stock Exchange Does XOMA (XOMA) Trade On?

XOMA is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for XOMA?

The stock symbol (also called a 'ticker') for XOMA is "XOMA."

What Is the Current XOMA Market Capitalisation?

As of today, XOMA (NASDAQ: XOMA) market cap is 491.40M USD.

What Is XOMA's (XOMA) Earnings Per Share (TTM)?

The XOMA EPS is currently 1.46 (Trailing Twelve Months).

When Is the Next XOMA Earnings Date?

XOMA's next earnings report will be released on 05/05/2026.

Is XOMA a Buy or Sell From a Technical Analyst Perspective?

Based on today's XOMA moving averages and other technical indicators, the daily buy/sell signal for XOMA stock is Strong Buy.

How Many Times Has XOMA Stock Split?

XOMA has split 2 times. (See the XOMA stock split history page for full effective split date and price information.)

How Many Employees Does XOMA Have?

XOMA has 14 employees, based on their latest Companies House report.

What is the current trading status of XOMA (NASDAQ: XOMA)?

As of 05/05/2026, XOMA (XOMA) is trading at a share price of 41.22 USD, with a previous close of 41.04 USD. The stock has fluctuated within a day range of 41.09 USD to 41.48 USD, while its 52-week range spans from 22.29 USD to 42.81 USD.

What Is XOMA (XOMA) Price Target According to Analysts?

The average 12-month price target for XOMA is 42.67 USD, with a high estimate of 50 USD and a low estimate of 39 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +3.51% Upside potential.

What Is the XOMA Premarket Price?

XOMA's last pre-market stock price is 41.10 USD. The pre-market share volume is 20.00, and the stock has decreased by 0.06, or 0.15%.

What Is the XOMA After Hours Price?

XOMA's last after hours stock price is 41.32 USD, the stock has decreased by 0.28, or 0.68%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.